Avalo Therapeutics (AVTX) Income from Discontinued Operations (2019 - 2021)
Powered by 
Analysis
Avalo Therapeutics (AVTX) Income from Discontinued Operations (2019 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 10 | Avalo Therapeutics | 840.43 Mn | 840.43 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -65,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 69,000.00 |
| Mar 31, 2021 | -106,000.00 |
| Dec 31, 2020 | 499,000.00 |
| Sep 30, 2020 | -198,000.00 |
| Jun 30, 2020 | -455,000.00 |
| Mar 31, 2020 | 1.04 Mn |
| Dec 31, 2019 | 7.25 Mn |
| Sep 30, 2019 | -1.09 Mn |
| Jun 30, 2019 | -3.68 Mn |
| Mar 31, 2019 | -2.29 Mn |